(9H-fluoren-9-yl)methyl (4-hydroxybutyl)carbamate, 95%, 1g

1-(piperidin-2-yl)ethanone, 98+%, 1g

(2-Methoxy-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 98%, 5g

4-BROMO-2,3-DIFLUOROPHENYLACETONITRILE, 95.0%, 100mg

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 5 ml, 3500–5000 dalton(s), 12 pièce(s)

5-(Diphenylamino)thiophene-2-carbaldehyde, 97%, 1g

4-Bromo-2-fluoro-N-(2-iodophenyl)-benzenesulfonamide, 95%, 250mg

2-[(1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoic acid, 98%, 1g

5-Trifluoromethyl-benzo[b]thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

1-(Tert-butyl) 3-ethyl 5,5-difluoro-4-hydroxypiperidine-1,3-dicarboxylate, 98+%, 10g

4-BROMO-2-FORMYLBENZOIC ACID, 95.0%, 1g

3-OXOCYCLOPENTANE-1-CARBONITRILE, 95.0%, 100mg

Acetamide, N-[2-[[[2-methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]-, 98%, 1g